Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    HealthTech BioActives, leading globally in Flavonoids and Vitamin B12 Derivatives.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Menu

    Lutetium-177 Vipivotide Tetraxetan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Pluvicto

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Pluvicto

    Lutetium Lu 177 Vipivotide Tetraxetan

    arrow
    PackExpo
    Not Confirmed

    Brand Name : Pluvicto

    Switzerland
    arrow
    PackExpo
    Not Confirmed

    Novartis

    Lutetium Lu 177 Vipivotide Tetraxetan

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 271

    2021 Revenue in Millions : 0

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Pluvicto

    Lutetium Lu 177 Vipivotide Tetraxetan

    arrow
    PREP
    Not Confirmed

    Brand Name : Pluvicto

    Switzerland
    arrow
    PREP
    Not Confirmed

    Novartis

    Lutetium Lu 177 Vipivotide Tetraxetan

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 980

    2022 Revenue in Millions : 271

    Growth (%) : 262

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Pluvicto

    Lutetium Lu 177 Vipivotide Tetraxetan

    arrow
    PREP
    Not Confirmed

    Brand Name : Pluvicto

    Switzerland
    arrow
    PREP
    Not Confirmed

    Novartis

    Lutetium Lu 177 Vipivotide Tetraxetan

    Main Therapeutic Indication : Oncology

    Currency : USD

    2024 Revenue in Millions : 1,392

    2023 Revenue in Millions : 980

    Growth (%) : 42

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF